Ask AI

Downloadable Slides

Share

Program Content

Activities

  • Targeting DLL3 for EP NECs
    Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 30, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.